Alleviation of Symptom Burden Following Deep Brain Stimulation in Moderate to Severe Brain Injury
Linda M. Gerber, Nancy R. Temkin, Jason Chua, Jason Barber, Jonathan D. Victor, Jaimie M. Henderson, Joseph T. Giacino, Nicholas D. Schiff
Many patients experience high symptom burden for many years following moderate to severe traumatic brain injury (TBI). Here, we use the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), a self-report questionnaire that tracks the severity of chronic symptoms that impact quality of life, to evaluate longitudinal changes following deep brain stimulation (DBS) in participants with chronic, moderate to severe TBI (msTBI) and to compare findings to the natural recovery observed in the TRACK-TBI Longitudinal cohort. The DBS cohort consisted of the five participants with msTBI in the CENTURY-S trial (CENtral Thalamic Deep Brain Stimulation for the Treatment of Traumatic Brain InjURY, NCT02881151) who received DBS. The total mean RPQ score decreased from 35.0 (SD 8.7) to 18.4 (SD 18.5). 3 participants reporting 10, 8, and 4 symptoms (of a possible 16) as moderate or severe at baseline reported 0 symptoms at this level at treatment end. A fourth participant showed a 50% decrease in the number of moderate to severe symptoms, from 10 to 5. A sample of 107 patients with msTBI from the TRACK-TBI Longitudinal study served as a comparison group. The TRACK-TBI Longitudinal RPQ total score remained stable from 1-year post-injury (mean 13.84. SD 12.61) to the first follow-up at either 2, 3, 4, or ≥5 years post-injury (mean 14.47. SD 12.98). More TRACK-TBI Longitudinal participants experienced worsening moderate to severe symptoms than improvement (increased: